Fate Therapeutics, Inc. , a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators to treat orphan diseases, announced today that Christian Weyer, M.D., M.A.S., President and Chief Executive Officer, will present an overview of the company's programs at the Piper Jaffray 26th Annual Healthcare Conference on Tuesday, December 2nd, 2014 at 12:10 pm EST in New York, NY. A live webcast can be accessed under "Events & Presentations" in the Investors and Media section of the Company's website at http://ift.tt/1psDMU5 .
http://ift.tt/15zq5gq
http://ift.tt/15zq5gq
No comments:
Post a Comment